Joel Greenblatt acquired 24.3 Thousand Apellis Pharmaceuticals shares worth $420 Thousand. That's 0.00% of their equity portfolio (1092nd largest holding). The first Apellis Pharmaceuticals trade was made in Q3 2022. Since then Joel Greenblatt bought shares three more times and sold shares on four occasions. The investor's estimated purchase price is $734 Thousand, resulting in a loss of 43%.